Table 3.
Comparison of liver disease and outcomes among HCV patients.
| aPRR/aMR | LCL | UCL | p-value | |
|---|---|---|---|---|
| Liver cirrhosis | 0.81 | 0.72 | 0.91 | 0.0004 |
| Liver cancer∗ | 0.79 | 0.55 | 1.13 | 0.2013 |
| Complications of cirrhosis | ||||
| Ascites | 0.62 | 0.50 | 0.76 | <0.0001 |
| Variceal bleeding | 1.03 | 0.75 | 1.40 | 0.8658 |
| Hepatorenal syndrome | 0.78 | 0.42 | 1.45 | 0.436 |
| Hepatic encephalopathy | 0.68 | 0.38 | 1.20 | 0.1824 |
| Portal hypertension | 0.71 | 0.56 | 0.91 | 0.0065 |
| Jaundice | 0.64 | 0.34 | 1.20 | 0.1633 |
| Baveno4 | 0.97 | 0.93 | 1.02 | 0.2167 |
| Health care utilization | ||||
| Inpatient mortality∗ | 0.84 | 0.60 | 1.17 | 0.298 |
| Length of stay∗ | 0.99 | 0.93 | 1.05 | 0.6319 |
| Total hospital cost∗ | 0.87 | 0.80 | 0.95 | 0.0012 |
| Unfavourable discharge∗ | 0.85 | 0.77 | 0.95 | 0.0025 |
aPRR: adjusted prevalence rate ratio; aMR: adjusted mean ratio (LOS and total hospital cost). LCL and UCL: lower and upper confidence limit; ∗: effects are after adjusting for cirrhosis.